Introduction to the topic
Proteins are central to drug development, either as targets for drugs or as drugs themselves (biopharmaceuticals). Advanced analytical techniques are needed to characterize the complex dynamic structure and interactions of proteins. Our research group at UCPH has world-leading expertise in the use of mass spectrometry (MS) to analyze proteins, and the goal of this research project is to use MS to provide critical new information concerning the structure and interactions of two proteins involved in blood coagulation – to develop improved drugs to treat hemophilia.
Project details
In the first phase of this project, the Research Assistant will learn and gain real-world competency with liquid chromatography and mass spectrometry (LC-MS) techniques to interrogate various aspects of protein structure, including HDX-MS, an incredibly sensitive labeling method for studying the conformation, dynamics and interactions of proteins. The second phase of the project involves collaborating with researchers at the danish pharmaceutical company Novo Nordisk to apply MS to study the structure of two proteins, FIX and FX, two key coagulation factors that play a key role in blood coagulation. The third phase of the project involves use of HDX-MS to study the interactions between FIX and FX and bispecific antibody drugs that have been developed at Novo Nordisk to module this interaction and thereby enhance blood coagulation and treat hemophilia.
The project spans several semesters and as a Research Assistant, you will contribute to a particular phase of the project depending on when you join. Activities will include both literature studies and a lot of hands-on lab work, such as protein sample preparation and peptide mapping, liquid chromatography and mass spectrometry (LC-MS) and HDX-MS – and data analysis.
You will gain in-depth knowledge of the subject matter and build practical lab skills tailored to the objectives in each phase of the project. The project represents a rare opportunity to gain experience with cutting-edge bioanalytical science and be part of an exciting research collaboration involving researchers from both university and pharmaceutical industry.
Syllabus
Coming soon
Selected relevant publications
– Trabjerg, E, Nazari, Z.E., Rand, K.D. (2018). Conformational analysis of complex protein states by hydrogen/deuterium exchange mass spectrometry (HDX-MS): Challenges and emerging solutions. Trends in Analytical Chemistry. 106: 125. DOI: https://doi.org/10.1016/j.trac.2018.06.008
– Stænder, S.H.D., Reboul, C.F., (….)., Rand, K.D, Buckle, A.M. (2025). Structure and dynamics of GAD65 in complex with an autoimmune polyendocrine syndrome type 2-associated autoantibody. Nature Communications. 16: 2275. DOI: 10.1038/s41467-025-57492-4
– Trabjerg, E, Nilsen J., (…), Leitner, A., Rand, K.D. (2025). Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation. Communications Biology. 8:922. DOI: 10.1038/s42003-025-08252-z
Prerequisites
One year of biology/chemistry and one year of biochemistry at university level.
Additional research application required
You will need to submit an additional research application through Student Registration in order to enroll in this course.
To submit your research application, you must already be admitted to DIS.
All research application materials must be submitted on the following dates by 23:59 Central European Time:
– November 1 for spring semester applicants
– May 1 for fall semester applicants
Complete your additional research application through Student Registration.
If you are not already enrolled, use this link to apply to DIS before completing a research application.